Dec 31, 2023

Alkermes Q4 2023 Earnings Report

Alkermes reported financial results for the fourth quarter and year ended December 31, 2023, and provided financial expectations for 2024.

Key Takeaways

Alkermes reported Q4 2023 financial results, with total revenues of $377.5 million. The company's proprietary product net sales increased year-over-year. GAAP net income for the quarter was $112.8 million. The company provided financial expectations for 2024, including generating a 30% EBITDA margin.

Total revenues for Q4 2023 were $377.5 million.

GAAP net income for Q4 2023 was $112.8 million.

The company expects to generate a 30% EBITDA margin in 2024.

LYBALVI revenues for the fourth quarter grew 61% compared to Q4 2022.

Total Revenue
$377M
Previous year: $305M
+23.9%
EPS
$0.48
Previous year: $0.14
+242.9%
Gross Profit
$298M
Previous year: $251M
+19.0%
Cash and Equivalents
$813M
Previous year: $292M
+178.1%
Free Cash Flow
$90.2M
Previous year: -$8.98M
-1104.4%
Total Assets
$2.14B
Previous year: $1.96B
+8.8%

Alkermes

Alkermes

Alkermes Revenue by Segment

Forward Guidance

Alkermes provided financial expectations for 2024.

Revenue & Expenses

Visualization of income flow from segment revenue to net income